Abstract The World Health Organization (WHO) advocates population-based screening
programs to reduce the global incidence of cervical cancer. However, screening guidelines …

Background The systematic review on which this paper is based provided evidence for the
Canadian Task Force on Preventive Health Care to update their guideline regarding …

Purpose: We conducted this targeted systematic evidence review of five key questions to
assist the US Preventive Services Task Force (USPSTF) in updating its 2003 …

Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases
annually and approximately 350,000 cancer-related deaths per year. The disease burden is …

Background Screening reduces cervical cancer incidence and mortality. Objective To
describe cervical cancer epidemiology and screening guidelines in six low-and middle …

Importance The number of deaths from cervical cancer in the United States has decreased
substantially since the implementation of widespread cervical cancer screening and has …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

The remarkable success achieved in cervical cancer prevention is largely attributable to
cervical cytology screening, also known as the Papanicolaou (Pap) test. The American …

Background: Cervical screening consumes substantial resources, but little is known about
utilization in the United States or compliance with guideline recommendations. Methods: To …

Cervical cancer is relatively rare in high‐income countries, where organized screening
programs are in place, as well as opportunistic ones. As the human papillomavirus (HPV) …